Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
03.04.Takeda receives NICE recommendation for Adcetris combination in Hodgkin lymphoma
03.04.Pfizer and Flagship Pioneering enter autoimmune disease partnership
03.04.Life sciences in Europe - the top 20 global cities
02.04.BMS receives positive CHMP opinion for perioperative Opdivo regimen in lung cancer
02.04.BeiGene's Tevimbra recommended by CHMP to treat small cell lung cancer
02.04.Organon/Henlius announce EMA validation for Perjeta biosimilar HLX11
02.04.ALS - innovative developments and investigational treatments
01.04.AstraZeneca's Imfinzi regimen approved by FDA to treat bladder cancer
01.04.Novartis' Pluvicto granted FDA approval for expanded prostate cancer use
01.04.Pfizer's RSV vaccine receives EC approval for individuals aged 18 to 59 years
01.04.OPEN Health appoints Matt D'Auria as CEO
01.04.Is critical thinking at risk?
31.03.Sanofi's Qfitlia granted FDA approval to treat haemophilia A or B
31.03.Johnson & Johnson's Tremfya recommended by CHMP to treat Crohn's disease
31.03.FDA approves Exelixis' Cabometyx to treat advanced neuroendocrine tumours
31.03.Brand building: pharma's billion dollar blind spot
31.03.PMLiVE's Top Pharma list - results and predictions for global drug sales
28.03.Merck granted EC approval for adult-specific pneumococcal vaccine Capvaxive
28.03.Biogen unveils plans for new global headquarters and R&D hub in US
28.03.LEO and Reig Jofre partner to improve access to psoriasis therapy in Europe
28.03.PM Society announces launch of PMi Awards 2025
28.03.Women in pharma
27.03.GSK's antibiotic Blujepa granted FDA approval to treat urinary tract infections
27.03.J&J shares overall survival results for Rybrevant/Lazcluze combination in lung cancer
27.03.FDA approves Soleno's Vykat XR as first treatment for hyperphagia in Prader-Willi syndrome